Section Arrow
IMTX.NASDAQ
- Immatics NV
Quotes are at least 15-min delayed:2026/01/07 12:25 EST
Regular Hours
Last
 9.815
+0.215 (+2.24%)
Day High 
10.19 
Prev. Close
9.6 
1-M High
10.9 
Volume 
149.43K 
Bid
9.8
Ask
9.83
Day Low
9.57 
Open
9.69 
1-M Low
9.13 
Market Cap 
1.29B 
Currency 美元 
P/E 29.95 
%Yield -- 
10-SMA 10.17 
20-SMA 10.1 
50-SMA 10.1 
52-W High 12.41 
52-W Low 3.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.93/--
Enterprise Value
1.30B
Balance Sheet
Book Value Per Share
3.64
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
155.84M
Operating Revenue Per Share
0.69
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.138+0.033+31.43%-- 
GLUEMonte Rosa Therapeutics24.11+8.1+50.59%54.09PE
VTYXVentyx Biosciences13.75+3.7+36.82%-- 
RXRXRecursion Pharmaceuticals4.8351+0.2851+6.27%-- 
MREOMereo BioPharma Group plc0.39555+0.01655+4.37%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.